secwatch.observer — SEC 8-K summary
======================================

Issuer:     Scilex Holding Co (SCLX)
CIK:        0001820190
Form:       8-K
Filed at:   2025-11-04T23:59:59+00:00
Accession:  0001193125-25-264143
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Scilex in-licenses Datavault AI tech for biotech asset tokenization; $10M upfront, $2.55B milestones
--------------------------------------------------------------------------------

- Worldwide exclusive license from Datavault AI for tokenizing genomic, DNA, diagnostic, therapeutic data in biotech/pharma.
- Non-refundable upfront fee $10M payable in four equal $2.5M quarterly installments starting Dec 31, 2025.
- Potential sales milestone payments up to $2.55B and 5% royalty on net sales; minimum annual royalty $1M after 24 months.
- Core patent includes 'Platform and Method for Tokenizing DNA Data' (U.S. Pat. App. 17/941,623) plus suite of issued/pending patents.
- Scilex aims to create a Biotech Exchange platform for secure tokenization, trading, and monetization of biotech assets.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1820190/000119312525264143/0001193125-25-264143-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1820190/000119312525264143/sclx-20251104.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-264143

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer